Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PTE save search
PolarityTE Announces $5.0 Million Registered Direct Offering
Published: 2022-03-16 (Crawled : 13:30) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -13.97%
H: 19.83%
C: 14.03%
offering
PolarityTE Provides Update on U.S. FDA Investigational New Drug Application for SkinTE®
Published: 2021-08-24 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -22.37%
H: 18.5%
C: 17.25%
new drug fda drug skin application
PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers
Published: 2022-05-03 (Crawled : 18:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -1.04%
H: 14.36%
C: 3.87%
skinte drug diabetic enroll
PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022
Published: 2022-09-13 (Crawled : 13:20) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.35%
H: 13.98%
C: 8.06%
global conference
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 3.81%
H: 11.07%
C: -3.92%
skinte fda fda approval skin approval phase 3
PolarityTE Announces Formation of Strategic Review Committee
Published: 2021-01-11 (Crawled : 19:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 18.18%
H: 10.9%
C: -19.87%
ev
PolarityTE Announces Diabetic Foot Ulcer Trial Met Primary and Secondary Endpoint
Published: 2021-05-10 (Crawled : 16:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 29.34%
H: 9.52%
C: -4.76%
trial diabetic diabetes
PolarityTE Announces Submission of Complete Response to FDA's Clinical Hold Correspondence for SkinTE® Investigational New Drug Application
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.56%
H: 8.75%
C: 8.7%
skinte clinical hold new drug fda application drug skin pons submission response
Eargo, Inc. CLASS ACTION REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Eargo, Inc.
Published: 2021-11-11 (Crawled : 17:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -1.94%
H: 8.38%
C: 2.51%
NNOX | $9.36 0.97% 0.96% 940K
|
Health Technology
|
| O: 1.26%
H: 0.49%
C: -2.27%
EAR | $2.57 7.78% 200K
|
Health Technology
|
| O: -4.75%
H: 0.0%
C: -6.79%
ema
Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer
Published: 2022-04-22 (Crawled : 14:20) - biospace.com/
SLDX | $0.0633 416.75% 230
|
Information
|
| O: 34.82%
H: 2.1%
C: 2.1%
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.19%
H: 7.95%
C: -1.1%
diagnostics diagnostic
PolarityTE Announces Closing of $5.0 Million Registered Direct Offering
Published: 2022-03-16 (Crawled : 21:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -3.54%
H: 7.73%
C: 4.36%
offering
PolarityTE to Report Third Quarter Financial Results on November 10, 2021
Published: 2021-10-28 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -2.73%
H: 6.32%
C: 5.94%
financial results results
PolarityTE Provides Update on Investigational New Drug Application
Published: 2021-10-07 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1.76%
H: 5.58%
C: -0.27%
new drug drug application
PolarityTE Announces Completion of Target Enrollment in Diabetic Foot Ulcer Trial
Published: 2021-01-21 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.93%
H: 4.63%
C: 0.0%
trial diabetic diabetes enroll
PolarityTE Provides Corporate Update
Published: 2021-02-10 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.6%
H: 4.43%
C: 3.8%
PolarityTE to Report Fiscal Year 2020 Financial Results on March 30, 2021
Published: 2021-03-10 (Crawled : 18:01) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.0%
H: 4.32%
C: -7.91%
financial results results
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-16 (Crawled : 12:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1599.62%
H: 4.16%
C: -5.48%
results
PolarityTE Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Published: 2021-01-12 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -9.2%
H: 3.96%
C: -2.2%
offering nasdaq
PolarityTE Announces $8.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Published: 2020-12-22 (Crawled : 16:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -4.57%
H: 3.08%
C: 1.62%
offering nasdaq
Healthtech Solutions, Inc. Announces Appointment of Paul Mann to the Board of Directors
Published: 2021-07-20 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $90.08 1.06% -0.28% 9.5M
|
Finance
|
| O: 1.0%
H: 3.01%
C: 2.62%
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -0.32%
H: 7.38%
C: 5.46%
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.